# Congressional stock trades in WUXIF (WuXi AppTec Co., Ltd.)

Congressional stock trades in WuXi AppTec Co., Ltd. (WUXIF) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.

- Industry: Diagnostics & Research
- Last close: $27
- Price updated: Oct 20, 2026
- Total congressional trades: 1
- Politicians trading: 1
- Last traded: Sep 18, 2026
- Source: https://tryglasshouse.ai/companies/WUXIF.md

## Trading History

- Page: 1 of 1
- Results: 1 of 1
- Pagination query parameter: `page`

## 1. Gilbert Ray Cisneros, Jr.

- Member: Democrat, House
- Transaction: Buy, $1,001 - $15,000
- Dates: traded Sep 18, 2026, disclosed Oct 12, 2026
- Market context: $26.08 at trade, $27 current (+3.53%)
- Politician: https://tryglasshouse.ai/politicians/C001123.md
- Record: https://tryglasshouse.ai/trades/f7452f41-b700-48de-9805-003f4eeff30e.md



## About WuXi AppTec Co., Ltd.

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People's Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions which support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides laboratory testing services, such as toxicology, DMPK, and bioanalytical services; clinical contract research organization services, including Phase I to Phase IV clinical development services, and bioequivalence for products including pharmaceuticals and biologics; and site management organization, patient recruitment, site start-up, and academic research organization. In addition, it offers services for biology; CDRMO platform for small molecules, oligonucleotides, and peptides; drug research and development testing; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.

Prices and percentage changes are market context, not portfolio returns. This information is not financial advice.